Current approaches in treatment of triple-negative breast cancer

查看全文 作　　者：Hanan Ahmed [1]Wahba;Hend Ahmed El-[1]Hadaad

机构地区：[1]Clinical Oncology and Nuclear Medicine, Mansoura University

出　　处：《Cancer Biology & Medicine》索引2015年第12卷第2期,共11页

摘　　要：Triple-negative breast cancer(TNBC) is diagnosed more frequently in younger and premenopausal women and is highly prevalent in African American women. TNBC is a term derived from tumors that are characterized by the absence of ER, Pg R, and HER2. So patients with TNBC do not benefit from hormonal or trastuzumab-based therapies. TNBCs are biologically aggressive, although some reports suggest that they respond to chemotherapy better than other types of breast cancer, prognosis remains poor. This is due to: shortened disease-free interval in the adjuvant and neoadjuvant setting and a more aggressive course in the metastatic setting. 关键词：乳腺癌治疗阴性反应比设置单抗化疗

相关文献

参考文献（75）
引证文献（26）
耦合文献（0）

参考文献(75)

引证文献(26)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Current approaches in treatment of triple-negative breast cancer

参考文献(75)

引证文献(26)

用户提示